European Journal of Heart Failure · 2009 · 119 citations · 31 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacovigilanceAnemiaCardiac MedicationsCardiac PharmacotherapyHeart FailureHeart Failure PharmacotherapyChronic Heart Failure ManagementCongestive Heart Failure ManagementHeart Failure PharmacologySafety In Heart Failure
BACKGROUND: Patients with heart failure (HF) and anaemia have greater functional impairment, worse symptoms, increased rates of hospital admission, and a higher risk of death, compared with non-anaemic HF patients. Whether correcting anaemia can improve outcomes is unknown. OBJECTIVE: The Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF; Clinical Trials.gov NCT 003 58215) was designed to evaluate the effect of the long-acting erythropoietin-stimulating agent darbepoetin alfa on mortality and morbidity (and quality of life) in patients with HF and anaemia. METHODS: Approximately 2600 patients with New York Heart Association class II-IV, an ejection fraction < or =40%, and a haemoglobin (Hb) consistently < or =12.0 g/dL but > or =9.0 g/dL will be enrolled. Patients are randomized 1:1 to double-blind subcutaneous administration of darbepoetin alfa or placebo. Investigators are also blinded to Hb measurements and darbepoetin alfa is dosed to achieve an Hb concentration of 13.0 g/dL (but not exceeding 14.5 g/dL) with sham adjustments of the dose of placebo. The primary endpoint is the time to death from any cause or first hospital admission for worsening HF, whichever occurs first. The study will complete when approximately 1150 subjects experience a primary endpoint.
31
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
Ajay Singh, Lynda A. Szczech, Kezhen L. Tang et al. · New England Journal of Medicine · 2006 · 2.8K citations · Full text
Anatole Besarab, W. Kline Bolton, Joan C. Egrie et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text
Donald S. Silverberg, Dov Wexler, Miriam Blum et al. · Journal of the American College of Cardiology · 2000 · 730 citations
Donald S. Silverberg, Dov Wexler, David S. Sheps et al. · Journal of the American College of Cardiology · 2001 · 646 citations